Finance

Lists
Q1 2027 earnings • released • Revenue beat +10.20%
See results
YATHARTH:NSE
Yatharth Hospital & Trauma Cre Srvcs Ltd
₹863.00
-0.31%
(-2.70) 1D
Aug 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for YATHARTH...
Open
₹862.60
High
₹880.00
Low
₹856.05
Mkt. cap
83.62B
Avg. vol.
0.00
Volume
431.38K
P/E ratio
47.42
52-wk high
₹919.50
52-wk low
₹538.25
EPS
₹18.20
No. of employees
5K
Open
₹862.60
High
₹880.00
Low
₹856.05
Mkt. cap
83.62B
Avg. vol.
0.00
Volume
431.38K
P/E ratio
47.42
52-wk high
₹919.50
52-wk low
₹538.25
EPS
₹18.20
No. of employees
5K
News stories
From web sources and news partners
Profile
Yatharth Hospital & Trauma Care Services Ltd is an Indian for-profit private hospital chain of North India. It operates 8 hospitals with more than 2500 beds in four states of India. It was founded by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar in 2008. All of its hospitals are accredited by NABH. Its facility in Greater Noida West is the first and only hospital in Uttar Pradesh to be accredited by Joint Commission International. Wikipedia
About Yatharth Hospital & Trauma Cre Srvcs Ltd
CEO-
Employees4.9K
Founded2008
Headquarters-
SectorHealth care provider
Websiteyatharthhospitals.com
Last report
Aug 11, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
3.93B / 3.56B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.79B
3.20B
3.42B
3.93B
Cost of goods sold
1.10B
1.26B
1.32B
-
Cost of revenue
1.10B
1.26B
1.32B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1.24B
1.44B
1.59B
-
Total operating expenses
2.34B
2.70B
2.92B
-
Operating income
455.91M
502.89M
499.15M
-
Other non operating income
94.89M
78.25M
71.08M
-
EBT including unusual items
548.23M
570.97M
519.52M
-
EBT excluding unusual items
548.23M
570.97M
519.52M
-
Income tax expense
135.70M
140.14M
72.54M
-
Effective tax rate
24.75%
24.54%
13.96%
-
Other operating expenses
1.05B
1.20B
1.29B
-
Net income
412.42M
453.51M
475.20M
-
Net profit margin
14.76%
14.15%
13.91%
11.85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.57M
-10.17M
-50.71M
-
Net interest expenses
-2.57M
-10.17M
-50.71M
-
Depreciation and amortization charges
189.31M
239.60M
299.96M
-
EBITDA
625.16M
639.36M
718.66M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps